- NCT00799409
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameMethylphenidate HClProduct NameCONCERTA®Therapeutic AreaBehaviors and Mental DisordersEnrollment78% Female29.5%% White58%
Product ClassStimulants/ADHD/AnorexiantsSponsor Protocol NumberCONCERTA-ATT-4069Data PartnerJohnson & JohnsonCondition StudiedAttention Deficit Hyperactivity DisorderMean/Median Age (Years)10.1
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2024-0860 : Predicting Methylphenidate Response in Adult-ADHD (A-ADHD) Using Machine Learning Approaches
- 2020-4444 : Expectancy Effects as a Confounding Factor in ADHD Treatment Research
- 2019-3958 : Machine Learning for predicting treatment efficacy and clinical categorizations across mental health disorders.
- 2015-0592 : Detection of uninformative clinics during the trial of a new drug using statistical and machine learning techniques